APEI

Rating neutralAI Memo

American Public Education

As of 2026-10-31/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-31 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Q3 enrollment and profitability test • 2026-11-30

Base target: $40 / p=50% prob

Biggest risk

APEI's Q3 adjusted EBITDA outlook of $14.0–$17.0 million is below the prior-year $20.7 million despite projected enrollment growth. Integration, education-funding and accreditation risks limit confidence in extrapolating Q2 results. [#SEC-8K-2026-08-10] [#SEC-10Q-2026-08-10]

Invalidation

Break below $31 or thesis failure.

What would change my mind?

Q2 revenue rose 5.5% year over year to $171.7 million, adjusted EBITDA rose 36.8% to $20.7 million, and management raised FY2026 guidance. Continued Health+ enrollment growth and successful integration could support upside. [#SEC-8K-2026-08-10]

Research note

Recommendation

neutral

Confidence

medium

As of

2026-10-31

Base target

$40

p=50%

Bull target

$49

p=25%

Bear target

$31

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Health+ growth and institutional integration
Q2 revenue rose 5.5% year over year to $171.7 million, adjusted EBITDA rose 36.8% to $20.7 million, and management raised FY2026 guidance.
Continued Health+ enrollment growth and successful integration could support upside.

BearKey bullets

Q2 operating cash flow fell to $12.1 million from $14.8 million a year earlier, while FY2026 capital-expenditure guidance is $25–$28 million versus $15.9 million in 2025.
[#SEC-8K-2026-08-10]
Q3 adjusted EBITDA guidance implies a year-over-year decline despite projected enrollment growth.

WatchKey bullets

Q3 enrollment and profitability test

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $40 (p=50%)

Target spread vs base: +23% / -22%

Scenario probabilities

Bull Target: $49 (p=25%)Base Target: $40 (p=50%)Bear Target: $31 (p=25%)

Commentary

Company-reported Q2 growth and raised guidance are constructive, but the weaker Q3 EBITDA outlook keeps this a monitoring view. No verified current price reaction, analyst revisions, options skew, short interest, employee score or sufficiently covered social measure was supplied; zero sentiment fields indicate unavailable data, not measured neutrality. The deterministic prior is neutral.

As of 2026-10-31 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Health+ growth and institutional integration

Scenarios

Bull Target (Scenario probability)

$49 / p=25% prob

Base Target (Scenario probability)

$40 / p=50% prob

Bear Target (Scenario probability)

$31 / p=25% prob

Analysis 2026-10-31 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-11-30
Q3 enrollment and profitability test
APEI projected 101,000–103,000 Military+ net course registrations, approximately 19,100 Health+ students and $14.0–$17.0 million of adjusted EBITDA for Q3. Results will test enrollment growth against the implied EBITDA decline from $20.7 million a year earlier. The reporting date is unconfirmed; November 30 is a monitoring estimate. [#SEC-8K-2026-08-10] [#10-Q-2026-08-10]
Prob 75.00% • Move 7.00% • Priced-in 50.00%
EVENT2027-03-31
Delivery against raised FY2026 outlook
The company raised FY2026 guidance to $690–$698 million of revenue, $96–$104 million of adjusted EBITDA and $2.48–$2.79 of diluted EPS. Delivery is a more meaningful test than extrapolating Q2 growth; the assessment date is an estimate, not an announced results date. [#SEC-8K-2026-08-10]
Prob 60.00% • Move 8.00% • Priced-in 55.00%

Short-term Catalysts

Next few weeks

No short-term catalysts

Long-term Catalysts

Months to a year

Health+ growth and institutional integration
2027-06-30
Health+ revenue grew 11.0% year over year in Q2, primarily on enrollment gains and modest tuition increases. APEI reported opening an Orlando campus and completing the combination of its three institutions into one accredited institution. Sustained enrollment and effective integration could support earnings, but benefits remain unproven. [#SEC-8K-2026-08-10]
Prob 55% • Move 10% • Priced-in 45%

Risks

Q2 operating cash flow fell to $12.1 million from $14.8 million a year earlier, while FY2026 capital-expenditure guidance is $25–$28 million versus $15.9 million in 2025. [#SEC-8K-2026-08-10]
Q3 adjusted EBITDA guidance implies a year-over-year decline despite projected enrollment growth. [#SEC-8K-2026-08-10]
The October 27 8-K concerns a board appointment, not an operating update or guidance change. [#8-K-2026-10-27]
The institutional combination carries execution and accreditation risk; the 10-Q identifies regulatory compliance and NCLEX standards among relevant risks. [#SEC-10Q-2026-08-10]

Peers

Symbol	Summary
LINC	Lincoln Educational Services is the packet's most relevant postsecondary-education comparator. No comparable current operating or valuation metrics were supplied, so a quantitative peer-multiple conclusion is not warranted.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-31